Ceftaroline fosamil laden allograft: A new modality in reducing infection?

Purpose: Allograft infection remains the greatest challenge in orthopaedic reconstructive surgery especially methicillin-resistant Staphylococcus aureus (MRSA). This risk can be minimized with the use of antibiotic laden allograft (ALA) via iontophoresis. Ceftaroline fosamil (CF) is an advanced-gene...

Full description

Bibliographic Details
Main Authors: Vivek Ajit Singh, Lim Han Sim, Amber Haseeb, Cindy Teh Shuan Ju
Format: Article
Language:English
Published: SAGE Publishing 2018-10-01
Series:Journal of Orthopaedic Surgery
Online Access:https://doi.org/10.1177/2309499018806671
_version_ 1818554426148782080
author Vivek Ajit Singh
Lim Han Sim
Amber Haseeb
Cindy Teh Shuan Ju
author_facet Vivek Ajit Singh
Lim Han Sim
Amber Haseeb
Cindy Teh Shuan Ju
author_sort Vivek Ajit Singh
collection DOAJ
description Purpose: Allograft infection remains the greatest challenge in orthopaedic reconstructive surgery especially methicillin-resistant Staphylococcus aureus (MRSA). This risk can be minimized with the use of antibiotic laden allograft (ALA) via iontophoresis. Ceftaroline fosamil (CF) is an advanced-generation cephalosporin, an alternative treatment for MRSA infections. Its antibacterial activity and safety profile are better than vancomycin. CF iontophoresed bone has not been used before. This study was conducted to establish the feasibility of creating a CF ALA and establish the prime conditions for its expenditure. Method: We created an iontophoresis cell; 3% CF was inserted within medullary segment of goat bone and sealed from external saline solution. The cell operated at the following voltages 30, 60 and 90 V and at the following durations 5, 10, 15, 20, 25 and 30 min. Information regarding optimal conditions for its application was then obtained. After which, correlation between voltages and time with CF concentration in the bone was analysed. A bioavailability test was also conducted to observe the optimal rate of CF elution from the graft. Result: The optimal condition for the impregnation process is 3% CF at 90 V for 10 min. Bone graft impregnated with CF at optimal conditions can elute above minimum inhibitory concentration of the CF against MRSA for 21 days. Conclusion: CF iontophoresis was found feasible for allograft impregnation. The technique is simple, inexpensive and reproducible clinically. Iontophoresis offers a novel solution to reduce the rate of perioperative infection in reconstructive surgery involving use of bone graft.
first_indexed 2024-12-12T09:39:20Z
format Article
id doaj.art-2c965d2f6876482aafff7a888edfbefe
institution Directory Open Access Journal
issn 2309-4990
language English
last_indexed 2024-12-12T09:39:20Z
publishDate 2018-10-01
publisher SAGE Publishing
record_format Article
series Journal of Orthopaedic Surgery
spelling doaj.art-2c965d2f6876482aafff7a888edfbefe2022-12-22T00:28:38ZengSAGE PublishingJournal of Orthopaedic Surgery2309-49902018-10-012610.1177/2309499018806671Ceftaroline fosamil laden allograft: A new modality in reducing infection?Vivek Ajit Singh0Lim Han Sim1Amber Haseeb2Cindy Teh Shuan Ju3 Department of Orthopedics, University of Malaya, Kuala Lumpur, Malaysia Department of Orthopedics, University of Malaya, Kuala Lumpur, Malaysia Department of Orthopedics, University of Malaya, Kuala Lumpur, Malaysia Department of Microbiology, University of Malaya, Kuala Lumpur, MalaysiaPurpose: Allograft infection remains the greatest challenge in orthopaedic reconstructive surgery especially methicillin-resistant Staphylococcus aureus (MRSA). This risk can be minimized with the use of antibiotic laden allograft (ALA) via iontophoresis. Ceftaroline fosamil (CF) is an advanced-generation cephalosporin, an alternative treatment for MRSA infections. Its antibacterial activity and safety profile are better than vancomycin. CF iontophoresed bone has not been used before. This study was conducted to establish the feasibility of creating a CF ALA and establish the prime conditions for its expenditure. Method: We created an iontophoresis cell; 3% CF was inserted within medullary segment of goat bone and sealed from external saline solution. The cell operated at the following voltages 30, 60 and 90 V and at the following durations 5, 10, 15, 20, 25 and 30 min. Information regarding optimal conditions for its application was then obtained. After which, correlation between voltages and time with CF concentration in the bone was analysed. A bioavailability test was also conducted to observe the optimal rate of CF elution from the graft. Result: The optimal condition for the impregnation process is 3% CF at 90 V for 10 min. Bone graft impregnated with CF at optimal conditions can elute above minimum inhibitory concentration of the CF against MRSA for 21 days. Conclusion: CF iontophoresis was found feasible for allograft impregnation. The technique is simple, inexpensive and reproducible clinically. Iontophoresis offers a novel solution to reduce the rate of perioperative infection in reconstructive surgery involving use of bone graft.https://doi.org/10.1177/2309499018806671
spellingShingle Vivek Ajit Singh
Lim Han Sim
Amber Haseeb
Cindy Teh Shuan Ju
Ceftaroline fosamil laden allograft: A new modality in reducing infection?
Journal of Orthopaedic Surgery
title Ceftaroline fosamil laden allograft: A new modality in reducing infection?
title_full Ceftaroline fosamil laden allograft: A new modality in reducing infection?
title_fullStr Ceftaroline fosamil laden allograft: A new modality in reducing infection?
title_full_unstemmed Ceftaroline fosamil laden allograft: A new modality in reducing infection?
title_short Ceftaroline fosamil laden allograft: A new modality in reducing infection?
title_sort ceftaroline fosamil laden allograft a new modality in reducing infection
url https://doi.org/10.1177/2309499018806671
work_keys_str_mv AT vivekajitsingh ceftarolinefosamilladenallograftanewmodalityinreducinginfection
AT limhansim ceftarolinefosamilladenallograftanewmodalityinreducinginfection
AT amberhaseeb ceftarolinefosamilladenallograftanewmodalityinreducinginfection
AT cindytehshuanju ceftarolinefosamilladenallograftanewmodalityinreducinginfection